摘要 |
<p>Methods of treating cancer with ganetespib are disclosed. Also provided are methods of treating a cancer wherein the cancer has a high level of hypoxia, with ganetespib. Also provided are methods of treating a cancer with a mutation in KRAS, a mutation in EGFR, or a mutation in ALK, with ganetespib. Further provided are methods of treating tumor/cancer with a mutation in KRAS, a mutation in EGFR, or a mutation in ALK wherein the tumor/cancer also has certain level of LDH, with ganetespib.</p> |